Its downregulation has been reported in many cancers (CRC, gastric cancer, medulloblastoma, breast cancer, prostate cancer, etc.), and its expression has been proved to be negatively correlated with VEGF expression in CRC tissues [40,41]. This evidence concerns the gene VEGFA and breast carcinoma.